BIND Insider Trading Activity and SEC Form 4 Filings
BIND insider trading summary
No open-market insider purchases or sales of BIND Therapeutics, Inc (BIND) have been reported on SEC Form 4 in the past 12 months.
Latest BIND insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 25, 2013 | Polaris Venture Partners Entrepreneurs' Fund V, L.P. | 10% Owner | Buy | $390K (26,000 @ $15.00) |
| Sep 25, 2013 | Polaris Venture Management Co. V, L.L.C. | 10% Owner | Buy | $390K (26,000 @ $15.00) |
| Sep 25, 2013 | Polaris Venture Partners Founders' Fund V, L.P. | 10% Owner | Buy | $390K (26,000 @ $15.00) |
| Sep 25, 2013 | Polaris Venture Partners Special Founders' Fund V, L.P. | 10% Owner | Buy | $390K (26,000 @ $15.00) |
| Sep 25, 2013 | Polaris Venture Partners V, L.P. | 10% Owner | Buy | $390K (26,000 @ $15.00) |
| Sep 25, 2013 | Terrance McGuire | 10% Owner | Buy | $390K (26,000 @ $15.00) |
| Sep 25, 2013 | Jonathan A Flint | 10% Owner | Buy | $390K (26,000 @ $15.00) |
| Sep 25, 2013 | Noubar Afeyan | Director | Buy | $300K (20,000 @ $15.00) |
| Sep 25, 2013 | Flagship Ventures Fund 2004 L P | 10% Owner | Buy | $300K (20,000 @ $15.00) |
| Sep 25, 2013 | Flagship Ventures General Partner LLC | 10% Owner | Buy | $300K (20,000 @ $15.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.